RESUMEN
Strangles, caused by Streptococcus equi subspecies equi, is a highly infectious disease of equines causing major health issues and financial losses. The aim of the study was to detect the presence of the SeM gene in Streptococcus equi isolated from equine suspected of having strangles. A cross-sectional study design was conducted from July to December 2022 in five districts of the central Gondar zone, Ethiopia. One-hundred sixty swab samples were taken from animals that had been clinically suspected. The SeM gene was detected using polymerase chain reaction, and the antimicrobial susceptibility test was performed using the Kirby-Bauer disc diffusion method. The binary logistic regression model was employed to test for statistical significance. In 31.87% (51/160) of the samples, Streptococcus equi species were isolated, and 31.37% (16/51) of these species carried the SeM gene. There was a significant amount of tetracycline (81.5%), erythromycin (81.5%), and vancomycin (75.5%) resistance among the 16 isolates. Strangles were more likely to be present in animals who shared feed containers (AOR = 7.59; 95% CI = 1.44-39.93), drank from the same water troughs (AOR = 7.74; 95% CI = 1.44-41.01), and spent the night together (AOR = 5.97; 95% CI 1.41-25.37). The findings of this study showed that the research areas harboured Streptococcus equi subspecies equi. Sharing feed containers and water troughs were potential sources of strangles infection; thus, these containers need to be cleaned regularly.
Asunto(s)
Antibacterianos , Enfermedades de los Caballos , Pruebas de Sensibilidad Microbiana , Infecciones Estreptocócicas , Animales , Caballos , Enfermedades de los Caballos/microbiología , Infecciones Estreptocócicas/veterinaria , Infecciones Estreptocócicas/microbiología , Estudios Transversales , Etiopía/epidemiología , Factores de Riesgo , Antibacterianos/farmacología , Streptococcus equi/genética , Streptococcus equi/aislamiento & purificación , Streptococcus equi/efectos de los fármacos , Farmacorresistencia Bacteriana/genética , StreptococcusRESUMEN
Knowledge about the defensive chemistry of coniferous trees has increased in recent years regarding a number of alkaloid compounds; in addition to phenolics and terpenes. Here, we show that Norway spruce (Picea abies (L.) H. Karst.), an important boreal zone tree species; accumulates 1,6-dehydropinidine (2-methyl-6-(2-propenyl)-1,6-piperideine) in its needles and bark. We reanalyzed previously published GC-MS data to obtain a full picture of 1,6-dehydropinidine in P. abies. 1,6-dehydropinidine appeared to especially accumulate in developing spring shoots. We used solid-phase partitioning to collect the alkaloid fraction of the sprouts and thin-layer chromatography to purify 1,6-dehydropinidine. The antibacterial properties of the 1,6-dehydropinidine fraction were tested using a broth microdilution method; with Streptococcus equi subsp. equi as a model organism. Based on our results 1,6-dehydropinidine is common in alkaloid extractions from P. abies (0.4 ± 0.03 mg g-1 dw in mature needles) and it is especially abundant in young spruce shoots (2.7 ± 0.5 mg g-1 dw). Moreover; 1,6-dehydropinidine extracted from P. abies sprouts showed mild antibacterial potential against Streptococcus equi subsp. equi (MIC 55 µg mL-1). The antibacterial activity of a plant compound thought of as an intermediate rather than an end-product of biosynthesis calls for more detailed studies regarding the biological function of these coniferous alkaloids.
Asunto(s)
Antibacterianos/química , Antibacterianos/farmacología , Picea/química , Abies/química , Alcaloides/química , Streptococcus , Streptococcus equi/efectos de los fármacosRESUMEN
Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) causes a wide variety of infections in many species. CD44 is a transmembrane adhesion molecule, expressed by various cell types, which has been implicated in several infection processes. The aim of this study was to examine the role of CD44 in S. zooepidemicus adherence to LA-4â¯cells (mouse lung adenoma). Dose-dependent adhesion with LA-4 may be effectively studied by flow cytometry. Adherence of S. zooepidemicus is reduced after treatment of cells with anti-CD44 antibody. Treatment of S. zooepidemicus with recombinant CD44 significantly reduced bacteria adherence. In addition, CD44 can directly bind to wild-type S. zooepidemicus, while the binding was decreased in the capsule deletion isogenic mutant. These data suggest that CD44 facilitates adherence of S. zooepidemicus to LA-4â¯cells.
Asunto(s)
Adhesión Bacteriana/fisiología , Receptores de Hialuranos/metabolismo , Streptococcus equi/metabolismo , Adenocarcinoma del Pulmón , Animales , Anticuerpos/farmacología , Adhesión Bacteriana/efectos de los fármacos , Adhesión Bacteriana/genética , Cápsulas Bacterianas/genética , Línea Celular , Receptores de Hialuranos/genética , Ratones , Proteínas Recombinantes/farmacología , Eliminación de Secuencia , Infecciones Estreptocócicas/microbiología , Streptococcus equi/efectos de los fármacos , Streptococcus equi/genéticaRESUMEN
Penicillin is administered intravenously (IV) or intramuscularly (IM) to horses for the prevention and treatment of infections, and both routes have disadvantages. To minimize these shortcomings, a 24-hr hybrid administration protocol (HPP) was developed. Our objective was to determine penicillin plasma concentrations in horses administered via HPP. Venous blood was collected from seven healthy horses administered IV potassium penicillin G at 0 and 6 hr and IM procaine penicillin G at 12 hr. Blood was collected at 2-hr intervals from 0 to 20 hr and at 24 hr. Plasma penicillin concentrations were measured using liquid chromatography and mass spectrometry. Penicillin susceptibility from equine isolates was examined to determine pharmacodynamic targets. The MIC90 of penicillin for 264 isolates of Streptococcus sp. was ≤0.06 µg/ml. For the 24-hr dosing interval, the mean plasma penicillin concentration was >0.07 µg/ml. Five horses (72%) exceeded 0.06 µg/ml for 98% of the dosing interval, and two horses exceeded this value for 52%-65% of the dosing interval. The HPP achieved mean plasma penicillin concentrations in healthy adult horses above 0.07 µg/ml for a 24-hr dosing interval. However, individual variations in plasma concentrations were apparent and deserve future clinical study.
Asunto(s)
Antibacterianos/farmacocinética , Caballos/sangre , Penicilinas/farmacocinética , Animales , Antibacterianos/administración & dosificación , Antibacterianos/sangre , Antibacterianos/farmacología , Cromatografía Liquida/veterinaria , Esquema de Medicación/veterinaria , Caballos/metabolismo , Inyecciones Intramusculares/veterinaria , Inyecciones Intravenosas/veterinaria , Espectrometría de Masas/veterinaria , Pruebas de Sensibilidad Microbiana , Penicilina G Procaína/administración & dosificación , Penicilina G Procaína/sangre , Penicilina G Procaína/farmacocinética , Penicilinas/administración & dosificación , Penicilinas/sangre , Penicilinas/farmacología , Staphylococcus aureus/efectos de los fármacos , Streptococcus equi/efectos de los fármacosRESUMEN
Streptococcus equi subsp. equi es el agente etiológico de la adenitis equina, una enfermedad infecciosa que afecta al tracto respiratorio superior y linfonódulos de cabeza y cuello de equinos. La terapia antimicrobiana tradicional incluye como antibiótico de primera elección a la penicilina G (PEN), a la que los estreptococos suelen ser sensibles. El objetivo de este trabajo fue estudiar el perfil de sensibilidad a distintos antimicrobianos de cepas de S. equi que circulan en la provincia de Buenos Aires, Argentina. Se estudiaron 92 aislamientos mediante el método de difusión con discos; los antimicrobianos evaluados fueron PEN, cefotaxima, eritromicina, tetraciclina, enrofloxacina (ENR), trimetroprima-sulfametoxazol (TMS), ciprofloxacina, clindamicina (CLI), estreptomicina (STR) y florfenicol. Se determinó la concentración inhibitoria mínima (CIM) de la PEN y de aquellos antimicrobianos frente a los cuales S. equi mostró resistencia o sensibilidad intermedia. Se obtuvieron altos porcentajes de sensibilidad a todos los antimicrobianos por el método de difusión y valores de CIM por debajo de los puntos de corte para PEN, TMS y CLI. Se identificaron cepas resistentes a ENR y STR, con CIM50, CIM9o y rangos de CIM por encima de los puntos de corte. Los resultados confirman que la PEN podría utilizarse empíricamente, ya que las cepas circulantes en Buenos Aires no mostraron resistencia a este antimicrobiano. Se enfatiza en la relevancia del uso racional de los antibióticos para lograr éxito terapéutico, evitar la cronicidad, la recidiva de infecciones y la aparición de resistencia.
Streptococcus equi subsp. equi is the etiologic agent of strangles, an infectious disease affecting the upper respiratory tract and head and neck lymph nodes of equines. Routine antimicrobial therapy includes penicillin (PEN) as antibiotic of first choice. Streptococci are usually susceptible to PEN and only a few antimicrobial studies had been performed. The aim of this work was to study the antimicrobial susceptibility profile of S. equi from Buenos Aires, Argentina. Ninety-two isolates were studied by the single disk method to PEN, cefotaxime, erythromycin (ERY), tetracycline, enrofloxacin (ENR), trimethoprim sulfamethoxazole (TMS), ciprofloxacin, clindamycin (CLI), streptomycin (STR) and florfenicol. Minimum inhibitory concentration (MIC) to PEN and antibiotics with resistance and intermediate susceptibility were tested. High percentages of susceptibility were obtained by the disk diffusion method and MIC values of PEN, TMS and CLI were found to be under the breakpoint values. Resistant strains of ENR and STR with MIC50, MIC90 and MIC ranges above breakpoints were identified. These findings confirm that PEN may be used empirically because resistant strains were not found in Buenos Aires. Emphasis is placed on the rational use of antibiotics to achieve therapeutic success, to prevent chronicity, recurrence of infections and the emergence of resistance.
Asunto(s)
Animales , Infecciones Estreptocócicas , Streptococcus equi , Enfermedades de los Caballos , Antiinfecciosos , Argentina , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/veterinaria , Pruebas de Sensibilidad Microbiana , Streptococcus equi/efectos de los fármacos , Enfermedades de los Caballos/microbiología , Enfermedades de los Caballos/tratamiento farmacológico , CaballosRESUMEN
Streptococcus equi subsp. equi is the etiologic agent of strangles, an infectious disease affecting the upper respiratory tract and head and neck lymph nodes of equines. Routine antimicrobial therapy includes penicillin (PEN) as antibiotic of first choice. Streptococci are usually susceptible to PEN and only a few antimicrobial studies had been performed. The aim of this work was to study the antimicrobial susceptibility profile of S. equi from Buenos Aires, Argentina. Ninety-two isolates were studied by the single disk method to PEN, cefotaxime, erythromycin (ERY), tetracycline, enrofloxacin (ENR), trimethoprim sulfamethoxazole (TMS), ciprofloxacin, clindamycin (CLI), streptomycin (STR) and florfenicol. Minimum inhibitory concentration (MIC) to PEN and antibiotics with resistance and intermediate susceptibility were tested. High percentages of susceptibility were obtained by the disk diffusion method and MIC values of PEN, TMS and CLI were found to be under the breakpoint values. Resistant strains of ENR and STR with MIC50, MIC90 and MIC ranges above breakpoints were identified. These findings confirm that PEN may be used empirically because resistant strains were not found in Buenos Aires. Emphasis is placed on the rational use of antibiotics to achieve therapeutic success, to prevent chronicity, recurrence of infections and the emergence of resistance.
Asunto(s)
Antiinfecciosos , Enfermedades de los Caballos , Infecciones Estreptocócicas , Streptococcus equi , Animales , Argentina , Enfermedades de los Caballos/tratamiento farmacológico , Enfermedades de los Caballos/microbiología , Caballos , Pruebas de Sensibilidad Microbiana , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/veterinaria , Streptococcus equi/efectos de los fármacosRESUMEN
Streptococcus equi ssp. zooepidemicus (S. zooepidemicus) is responsible for peritonitis, septicemia, meningitis, arthritis and several other serious diseases in various species. Recent studies have demonstrated that CD44 is implicated in the process of host defense against pathogenic microorganisms. In the present study, the role of CD44 in the host response to S. zooepidemicus infection was investigated in a mouse model. Upon intraperitoneal infection with S. zooepidemicus, the expression of CD44 on the peritoneal exudate cells from wild-type (WT) mice was increased. CD44 deficiency accelerated mortality, which was accompanied by increased peritoneal bacterial growth and dissemination to distant body sites. CD44 knock-out (KO) mice showed enhanced early inflammatory cell recruitment into the peritoneal fluid on S. zooepidemicus infection. In line with this, the expression of proinflammatory cytokines, chemokines in peritoneal exudate cells and peritoneal macrophages of CD44 KO mice were increased compared with those of WT mice. In addition, CD44 deficiency was associated with reduced expression of A20, a negative regulator in TLR signaling. Overall, the present study suggests that CD44 plays a protective role in antibacterial defense against S. zooepidemicus in mice.
Asunto(s)
Receptores de Hialuranos/genética , Inflamación/patología , Infecciones Estreptocócicas/microbiología , Streptococcus equi/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Macrófagos Peritoneales , Ratones , Ratones Noqueados , Infecciones Estreptocócicas/patologíaRESUMEN
Antimicrobial susceptibility test results for trimethoprim-sulfadiazine with Streptococcus equi subspecies are interpreted based on human data for trimethoprim-sulfamethoxazole. The veterinary-specific data generated in this study support a single breakpoint for testing trimethoprim-sulfamethoxazole and/or trimethoprim-sulfadiazine with S. equi This study indicates trimethoprim-sulfamethoxazole as an acceptable surrogate for trimethoprim-sulfadiazine with S. equi.
Asunto(s)
Antibacterianos/farmacología , Pruebas de Sensibilidad Microbiana/normas , Streptococcus equi/efectos de los fármacos , Sulfadiazina/farmacología , Combinación Trimetoprim y Sulfametoxazol/farmacología , Trimetoprim/farmacología , Medicina Veterinaria/normas , Animales , Combinación de Medicamentos , Pruebas de Sensibilidad Microbiana/métodos , Medicina Veterinaria/métodosRESUMEN
BACKGROUND: Treatment of subclinical carriers of Streptococcus equi subsp. equi with a gelatine-penicillin formulation deposited in the guttural pouch has been empirically proposed, but data on local tissue penicillin concentrations after treatment are lacking. METHODS: We analysed tissue levels of penicillin after administration into the guttural pouches of four healthy horses. Two horses received local treatment with gelatine-penicillin and two horses received local treatment with an intramammary formulation of penicillin. Tissues were harvested for analysis either 12 or 24 h later. CONCLUSION: Results indicate that local treatment may be effective, but more research on optimal drug formulations in a larger sample size is warranted.
Asunto(s)
Antibacterianos/administración & dosificación , Caballos/metabolismo , Penicilinas/administración & dosificación , Estructuras Animales , Animales , Antibacterianos/farmacocinética , Antibacterianos/uso terapéutico , Portador Sano/tratamiento farmacológico , Portador Sano/microbiología , Portador Sano/veterinaria , Endoscopía/veterinaria , Enfermedades de los Caballos/tratamiento farmacológico , Caballos/microbiología , Penicilinas/farmacocinética , Penicilinas/uso terapéutico , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/veterinaria , Streptococcus equi/efectos de los fármacos , Distribución TisularRESUMEN
UNLABELLED: During Streptococcus zooepidemicus fermentation, most carbon sources are used to synthesize lactic acid, which can inhibit strain growth and hyaluronic acid production. Here, we expressed bacterial haemoglobin (Vhb) in Strep. zooepidemicus. Due to highly efficient oxygen use, only 15·26 g l(-1) lactic acid was produced, which is 0·73 times the quantity produced by the control strain. Compared with the control strain (1·61 g l(-1) ), hyaluronic acid (HA) production in this strain did not substantially increase, only to 2·16 g l(-1) . Next, we used a series of N-methyl-N'-nitro-N-nitroso-guanidine (NTG) treatments and selection programmes. Finally, we generated a hyaluronidase-negative and rifampin-resistant mutant strain that produces high levels of HA. The optimum carbon concentration for maximum hyaluronic acid production is only 30 g l(-1) of sucrose, which is lower than the control strain (60 g l(-1) ). The oxygen transfer rate coefficient KL a increased significantly to 372 ± 53 h(-1) from 18 ± 4 h(-1) of the control. The optimum carbon source for this strain is 21 g l(-1) of sucrose, 9 g l(-1) of maltose and 5 g l(-1) of glutamic acid. Hyaluronic acid accumulated at 6·7 g l(-1) in the culture broth. However, the molecular weight of HA decreased from 1835 KDa (Control) to 429 kDa. The prepared low-molecular weight HA could function as potential antiangiogenic substances, antiviral and antitumour agents to possibly be used as functional food ingredients. SIGNIFICANCE AND IMPACT OF THE STUDY: Hyaluronic acid (HA) has been used for a wide range of applications in health, cosmetic and clinical fields. During fermentation of Streptococcus to produce HA, 80-85% of the carbon source is used to produce lactic acid and acetic acid, and only approx. 5 and 10% of the carbon source is used to produce HA and biomass respectively. Here, we expressed bacteria haemoglobin (Vhb) in Streptococcus zooepidemicus, which can dramatically inhibit lactic acid production. After NTG treatments and selection programmes, we identified a mutant strain with highly efficient hyaluronic acid production (6·7 g l(-1) ) under economic fermentation conditions.
Asunto(s)
Ácido Acético/metabolismo , Hemoglobinas/biosíntesis , Ácido Hialurónico/metabolismo , Ácido Láctico/metabolismo , Streptococcus equi/metabolismo , Biomasa , Fermentación , Ácido Glutámico/metabolismo , Hemoglobinas/genética , Maltosa/metabolismo , Metilnitronitrosoguanidina/farmacología , Rifampin/farmacología , Streptococcus equi/efectos de los fármacos , Streptococcus equi/genética , Sacarosa/metabolismoRESUMEN
OBJECTIVE: To evaluate the efficacy of various endotracheal tube disinfection strategies for elimination of Streptococcus zooepidemicus and Bordetella bronchiseptica. DESIGN: Experimental in vitro study. SAMPLE: 12 sterile endotracheal tubes. PROCEDURES: Endotracheal tubes were inoculated with S zooepidemicus or B bronchiseptica and subjected to 1 of 5 treatments (spraying with accelerated hydrogen peroxide solution [AHP] or soaking in one of the following: AHP, 0.5% chlorhexidine gluconate solution [CHG], 0.3% triclosan-containing soap solution, or tap water) or left untreated (controls). After 5 minutes, tubes were rinsed with water and swabbed for direct and enrichment culture. Culture results were scored semiquantitatively. Each isolate was tested separately (10 endotracheal tubes/isolate/treatment). RESULTS: No growth was identified by direct culture of any samples collected from CHG-treated endotracheal tubes, whereas S zooepidemicus and B bronchiseptica were each identified from 1 of 10 tubes sprayed or soaked with AHP and from all tubes (10/10 each) treated by other methods or used as controls. The CHG and AHP treatments resulted in significantly lower median growth scores after direct culture than did other treatments. After enrichment culture, samples from CHG-treated tubes had significantly lower growth scores than samples from AHP-treated tubes, which had significantly lower scores than samples from other treatment groups. CONCLUSIONS AND CLINICAL RELEVANCE: High-level disinfection (ie, elimination of all vegetative bacterial growth) was not achieved with any treatment tested. Although optimal approaches are not known, processing of endotracheal tubes with CHG or AHP appears to be the best approach when sterilization is not feasible.
Asunto(s)
Antiinfecciosos Locales/farmacología , Bordetella bronchiseptica/efectos de los fármacos , Desinfectantes/farmacología , Intubación Intratraqueal/veterinaria , Streptococcus equi/efectos de los fármacos , Clorhexidina/análogos & derivados , Clorhexidina/farmacología , Recuento de Colonia Microbiana , Desinfección/métodos , Contaminación de Equipos , Peróxido de Hidrógeno/farmacología , Intubación Intratraqueal/instrumentación , Triclosán/farmacologíaRESUMEN
Streptococcus suis and Streptococcus equi subsp. zooepidemicus are capable of infecting humans and various animals, causing significant problems for the worldwide swine industry. As antibiotic resistance has increased, lysosomal enzymes encoded by phages have shown potential for use against pathogenic bacteria. In this study, a novel bacteriophage lysin, Ply30, encoded by the S. suis prophage phi30c, was recombinantly expressed and purified. Ply30 showed high bacteriolysis activity on S. suis and S. equi subsp. zooepidemicus in vitro. The ratio of the optical density at 600 nm (OD600) with treatment versus the OD600 with no treatment for most tested S. suis and S. equi subsp. zooepidemicus strains decreased from 1 to <0.3 and <0.5, respectively, within 1 h. The results of plate viability assays showed that treated bacteria suffered a 1- to 2-log decrease in CFU within 1 h. The optimal concentration of Ply30 was 50 µg/ml, and the optimal pH was 7. Moreover, Ply30 maintained high activity over a wide pH range (pH 6 to 10). The MICs of Ply30 against Streptococcus strains ranged from 16 to 512 µg/ml. In vivo, a 2-mg dose of Ply30 protected 90% (9/10 mice) of mice from infection with S. equi subsp. zooepidemicus and 80% (8/10 mice) of mice from infection with S. suis. Seven days after lysin Ply30 treatment, bacterial loads were significantly decreased in all tested organs and blood compared with those at 1 h postinfection without Ply30 treatment. Ply30 showed in vitro and in vivo antimicrobial efficiency and protected mice against two kinds of bacterial infections, indicating that Ply30 may be an effective therapeutic against streptococci.
Asunto(s)
Antibacterianos/administración & dosificación , Endopeptidasas/administración & dosificación , Profagos/enzimología , Infecciones Estreptocócicas/tratamiento farmacológico , Streptococcus equi/efectos de los fármacos , Streptococcus suis/efectos de los fármacos , Estructuras Animales/microbiología , Animales , Antibacterianos/aislamiento & purificación , Antibacterianos/metabolismo , Bacteriólisis , Sangre/microbiología , Recuento de Colonia Microbiana , Modelos Animales de Enfermedad , Endopeptidasas/genética , Endopeptidasas/aislamiento & purificación , Endopeptidasas/metabolismo , Estabilidad de Enzimas , Concentración de Iones de Hidrógeno , Ratones , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Profagos/genética , Streptococcus equi/fisiología , Streptococcus suis/fisiología , Análisis de Supervivencia , Resultado del TratamientoRESUMEN
BACKGROUND: Polysaccharide hyaluronic acid (HA) was chemically modified with cysteine ethyl ester (CYS). By immobilization of the thiol-bearing ligand on the polymeric backbone the thiolated bioconjugate HA-CYS was obtained. METHODOLOGY & RESULTS: Mucoadhesion, permeation enhancement effect and stability was tested. Furthermore mechanical, physicochemical properties as well as mucoadhesive strength, swelling index and residence time on the mucosa were investigated. The developed thiolated bioconjugate displayed 1.5-fold improved mucoadhesiveness on buccal mucosa as well as an enhanced permeation behavior and 2.5-fold higher polymer stability. The near neutral pH and 2.49±0.49% cytotoxicity over 12-h studies indicated their non-irritability and biocompatible nature with biological tissues. Further, the model drug sulforhodamine 101 was incorporated to determine its drug release profiles, which revealed a 2.8-fold controlled release of HA-CYS in comparison to unmodified HA. CONCLUSION: Thus, the promising results encourage further investigations and exploitation of this versatile polysaccharide.
Asunto(s)
Materiales Biocompatibles/química , Cisteína/química , Ácido Hialurónico/análogos & derivados , Ácido Hialurónico/síntesis química , Compuestos de Sulfhidrilo/química , Adhesivos Tisulares/síntesis química , Animales , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Colorantes , Humanos , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Irritantes , Mucosa Bucal , Rodaminas , Solubilidad , Streptococcus equi/efectos de los fármacos , Porcinos , Adhesivos Tisulares/efectos adversosRESUMEN
This study aimed to identify changing antimicrobial resistance patterns in isolates commonly obtained from equine clinical submissions. Laboratory records from 1999 to 2012 were searched for equine samples from which Escherichia coli or Streptococcus species was isolated. Susceptibility to enrofloxacin, ceftiofur, gentamicin, penicillin G, trimethoprim sulfamethoxazole (TMPS) and tetracyclines was noted. Isolates were divided into those identified between 1999 and 2004 (Early) and between 2007 and 2012 (Late). The proportion of isolates resistant to each antimicrobial and multiple drug-resistant (MDR) isolates (≥3 antimicrobial classes) was compared between time periods. There were 464 isolates identified (242 Early; 222 Late). A significant increase in the percentage of E coli isolates resistant to ceftiofur (7.3-22.7 per cent, P=0.002), gentamicin (28.5-53.9 per cent, P<0.001), tetracyclines (48.4-74.2 per cent, P=0.002) and MDR (26.6-49.4 per cent, P=0.007) was identified. There was a significant increase over time in the percentage of all streptococcal species resistant to enrofloxacin, ranging from 0 per cent (Early) up to 63 per cent (Late) depending on species. For Streptococcus zooepidemicus, resistance over time to tetracyclines and MDR increased. There was also a decrease in the proportion of S zooepidemicus resistant to TMPS over time. An increase in resistance over time of common equine pathogens to a number of commonly used antimicrobials supports the responsible use of antimicrobials.
Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana , Infecciones por Escherichia coli/veterinaria , Escherichia coli/efectos de los fármacos , Enfermedades de los Caballos/tratamiento farmacológico , Streptococcus/efectos de los fármacos , Animales , Cefalosporinas/farmacología , Combinación de Medicamentos , Enrofloxacina , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/tratamiento farmacológico , Fluoroquinolonas/farmacología , Gentamicinas/farmacología , Caballos , Pruebas de Sensibilidad Microbiana/veterinaria , Penicilina G/farmacología , Streptococcus/aislamiento & purificación , Streptococcus equi/efectos de los fármacos , Streptococcus equi/aislamiento & purificación , Sulfametizol/farmacología , Tetraciclinas/farmacología , Trimetoprim/farmacología , Reino UnidoRESUMEN
REASONS FOR PERFORMING STUDY: Systemic administration of ceftiofur crystalline free acid (CCFA) may be a potential treatment for infectious endometritis caused by Streptococcus equi ssp. zooepidemicus (S. zooepidemicus) and other susceptible bacterial organisms in the mare. OBJECTIVE: To determine if i.m. administration of CCFA at the label dose will exceed the minimum inhibitory concentration (MIC) of S. zooepidemicus in the endometrium following single administration and multiple administration protocols. STUDY DESIGN: Experimental pharmacokinetic study. METHODS: Three mares (Group 1) were administered a single i.m. dose of CCFA (6.6 mg/kg bwt) and blood and endometrial biopsies were collected at selected intervals for 144 h. Six additional mares (Groups 2 and 3) received CCFA at times 0, 4, 11 and 18 days, and were sampled at predetermined times for 25 or 49 days, respectively. Plasma and tissue samples were analysed by high-pressure liquid chromatography with tandem mass spectrometry for desfuroylceftiofur acetamide concentration, which is a direct measure of all ceftofur and ceftiofur metabolites in the sample. RESULTS: A mean plasma desfuroylceftiofur acetamide concentration of 0.367 ± 0.0162 µg/ml (mean ± s.e.) was detected at 96 h following administration. Mean endometrial tissue concentration was 0.510 ± 0.0418 µg/g at 96 h and exceeded the MIC for S. zooepidemicus (0.25 µg/ml) throughout the 144 h monitoring period for Group 1. Mares in Groups 2 and 3, given multiple doses of CCFA, maintained plasma concentrations above the MIC for S. zooepidemicus for 25 days. Endometrial tissue levels remained above the MIC at most data collection points for 25 days. CONCLUSIONS: Ceftiofur crystalline free acid reaches appropriate endometrial tissue values to exceed the MIC of S. zooepidemicus, a common cause of bacterial endometritis. Therefore, CCFA should be effective in the treatment of equine bacterial endometritis caused by S. zooepidemicus and other susceptible bacterial pathogens in the mare.
Asunto(s)
Antibacterianos/farmacocinética , Cefalosporinas/farmacocinética , Endometrio/metabolismo , Caballos/metabolismo , Animales , Antibacterianos/administración & dosificación , Antibacterianos/sangre , Antibacterianos/metabolismo , Cefalosporinas/administración & dosificación , Cefalosporinas/sangre , Cefalosporinas/metabolismo , Farmacorresistencia Bacteriana , Endometrio/química , Femenino , Caballos/sangre , Inyecciones Intramusculares , Pruebas de Sensibilidad Microbiana , Streptococcus equi/efectos de los fármacos , Distribución TisularRESUMEN
The genetic diversity and antibiotic resistance profiles of 38 Streptococcus equi subsp. zooepidemicus isolates were determined from a kennelled canine population during two outbreaks of hemorrhagic pneumonia (1999 to 2002 and 2007 to 2010). Analysis of the szp gene hypervariable region and the 16S-23S rRNA intergenic spacer region and multilocus sequence typing (MLST) indicated a predominant tetO-positive, doxycycline-resistant ST-10 strain during 1999 to 2002 and a predominant tetM-positive doxycycline-resistant ST-62 strain during 2007 to 2010.
Asunto(s)
Enfermedades de los Perros/microbiología , Doxiciclina/farmacología , Farmacorresistencia Bacteriana , Variación Genética , Neumonía Bacteriana/veterinaria , Infecciones Estreptocócicas/veterinaria , Streptococcus equi/efectos de los fármacos , Animales , Antibacterianos/farmacología , Antígenos Bacterianos/genética , Proteínas Bacterianas/genética , ADN Espaciador Ribosómico/genética , Brotes de Enfermedades , Enfermedades de los Perros/epidemiología , Perros , Pruebas de Sensibilidad Microbiana , Tipificación de Secuencias Multilocus , Neumonía Bacteriana/epidemiología , Neumonía Bacteriana/microbiología , Infecciones Estreptocócicas/epidemiología , Infecciones Estreptocócicas/microbiología , Streptococcus equi/clasificación , Streptococcus equi/genética , Streptococcus equi/aislamiento & purificaciónRESUMEN
The goal of this retrospective study was to have a comprehensive picture of the ß-hemolytic streptococci of horses including tissue/organ distributions and susceptibility patterns against specific antimicrobials between January 1, 2000 and December 31, 2010. A total of 2,497 ß-hemolytic streptococci were isolated from 2,391 cases, of which Streptococcus equi subsp. zooepidemicus was the most frequent isolate (72.0%). Other species isolated were Streptococcus dysgalactia subsp. equisimilis (21.3%), Streptococcus equi subsp. equi (5.8%), and unidentified ß-hemolytic streptococci (0.9%). As expected, S. equi was mostly isolated from lymph node abscesses and the respiratory tract in foals and adult horses. Streptococcus equi subsp. zooepidemicus and S. equisimilis were mostly isolated from placenta, fetal tissues, and genital tract of horses; S. zooepidemicus and S. equisimilis were also recovered in significant numbers from a number of other organs including lung, liver, brain, kidney, and joints, indicating a much broader tissue tropism than S. equi. In addition, more than 1 Streptococcus spp. was recovered in 106 cases, indicating the co-existence of these bacteria in some horses. This data also suggested that S. equisimilis is a major bacterial agent of horses, contrary to present knowledge. Based on Kirby-Bauer antimicrobial susceptibility data, streptococci were found to be generally susceptible to cephalothin, erythromycin, nitrofurantoin, penicillin, and ticarcillin and clavulanate. Resistance to antimicrobials has not developed over the years, except for gentamicin and tetracycline against S. equisimilis.
Asunto(s)
Enfermedades de los Caballos/microbiología , Infecciones Estreptocócicas/veterinaria , Streptococcus , Animales , Antibacterianos/farmacología , Pruebas Antimicrobianas de Difusión por Disco/veterinaria , Enfermedades de los Caballos/diagnóstico , Caballos/microbiología , Estudios Retrospectivos , Infecciones Estreptocócicas/diagnóstico , Infecciones Estreptocócicas/microbiología , Streptococcus/efectos de los fármacos , Streptococcus/aislamiento & purificación , Streptococcus equi/efectos de los fármacos , Streptococcus equi/aislamiento & purificaciónRESUMEN
The objectives of this study were to determine the plasma and pulmonary disposition of gamithromycin in foals and to investigate the in vitro activity of the drug against Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) and Rhodococcus equi. A single dose of gamithromycin (6 mg/kg of body weight) was administered intramuscularly. Concentrations of gamithromycin in plasma, pulmonary epithelial lining fluid (PELF), bronchoalveolar lavage (BAL) cells, and blood neutrophils were determined using HPLC with tandem mass spectrometry detection. The minimum inhibitory concentration of gamithromycin required for growth inhibition of 90% of R. equi and S. zooepidemicus isolates (MIC(90)) was determined. Additionally, the activity of gamithromycin against intracellular R. equi was measured. Mean peak gamithromycin concentrations were significantly higher in blood neutrophils (8.35±1.77 µg/mL) and BAL cells (8.91±1.65 µg/mL) compared with PELF (2.15±2.78 µg/mL) and plasma (0.33±0.12 µg/mL). Mean terminal half-lives in neutrophils (78.6 h), BAL cells (70.3 h), and PELF (63.6 h) were significantly longer than those in plasma (39.1 h). The MIC(90) for S. zooepidemicus isolates was 0.125 µg/mL. The MIC of gamithromycin for macrolide-resistant R. equi isolates (MIC(90)=128 µg/mL) was significantly higher than that for macrolide-susceptible isolates (1.0 µg/mL). The activity of gamithromycin against intracellular R. equi was similar to that of azithromycin and erythromycin. Intramuscular administration of gamithromycin at a dosage of 6 mg/kg would maintain PELF concentrations above the MIC(90) for S. zooepidemicus and phagocytic cell concentrations above the MIC(90) for R. equi for approximately 7 days.
Asunto(s)
Antibacterianos/sangre , Antibacterianos/farmacocinética , Caballos/sangre , Caballos/metabolismo , Pulmón/metabolismo , Macrólidos/sangre , Macrólidos/farmacocinética , Animales , Antibacterianos/metabolismo , Femenino , Macrólidos/metabolismo , Masculino , Pruebas de Sensibilidad Microbiana , Rhodococcus equi/efectos de los fármacos , Streptococcus equi/efectos de los fármacos , Distribución TisularRESUMEN
The effect of phosphatidylcholine on the molecular weight properties of hyaluronic acid (HA) was studied in batch culture of Streptococcus zooepidemicus by adding phosphatidylcholine at the early stage of exponential phase. With the addition of 80 mg/L of phosphatidylcholine, maximum HA yield (2.47 g/L) and weight-average molecular weight (902.60 KDa) were achieved, increased by 17.4% and 67.1%, respectively, as compared to the control. Metabolic flux analysis was employed to study the mechanism of phosphatidylcholine on the molecular weight of HA. The normalized flux distribution maps based on fermentation data at phosphatidylcholine addition indicated that phosphatidylcholine resulted in higher flux flowing to the HA pathway and lower flux flowing to the glycolysis and biomass synthesis pathway, coupling with higher level of UDPNAG generation and extra regeneration of ATP. The GC-MS analysis of fatty acids in the plasma membrane showed that the addition of phosphatidylcholine could promote the mobility and permeability of the cell membrane, making the HA chain pass through the membrane more easily, thus decreasing the energy consumption. All these results led to higher molecular weight of hyaluronic acid.
Asunto(s)
Ácido Hialurónico/biosíntesis , Ácido Hialurónico/química , Fosfatidilcolinas/farmacología , Streptococcus equi/efectos de los fármacos , Streptococcus equi/metabolismo , Acetatos/metabolismo , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Ácidos Grasos/análisis , Fermentación/efectos de los fármacos , Glucosa/farmacología , Ácido Láctico/metabolismo , Lípidos de la Membrana/metabolismo , Redes y Vías Metabólicas/efectos de los fármacos , Peso Molecular , Streptococcus equi/citología , Streptococcus equi/crecimiento & desarrolloRESUMEN
Sulfadiazine (SDZ) and trimethoprim (TMP) concentrations were examined in plasma and pulmonary epithelial lining fluid (PELF), following intravenous and oral administration and compared to minimum inhibitory concentrations (MICs) of common bacterial isolates from equine lower airway infections. SDZ/TMP (25/5 mg/kg) was administered intravenously, intragastric or per os to fed horses, and blood samples were collected before and 11 times, over 24 h, after administration. PELF samples were collected via a tampon device four times after drug administration and analysed for drug concentrations. Additionally, MICs of SDZ and TMP alone and in combination were determined in a selection of clinical respiratory isolates. Bioavailability was 74% for SDZ and 46% for TMP after paste administration in fed horses. The degree of penetration of SDZ and TMP into PELF, as described by AUC(PELF) /AUC(plasma) ratios, was 0.68 and 0.72, respectively, after intravenous administration. After oral administration, the degree of penetration for SDZ and TMP was 0.92 and 0.46, respectively. MIC measurements using SDZ/TMP ratios of 5:1 and 10:1 did not affect the interpretation of the results. The results indicate that clinically relevant drug concentrations of mainly TMP are difficult to maintain in PELF, especially after oral administration of SDZ/TMP.